Functional MRI study from Taipei and Mayo Clinic identifies locus coeruleus–substantia nigra connectivity as the neural substrate of restlessness in
In a packed session at the 2026 Annual Meeting of the American Academy of Neurology, leading specialists presented compelling evidence
Headache medicine is being quietly rewritten, and Liza Smirnoff, MD, of the University of Miami laid out the case today
In a wide-ranging “Updates in Epilepsy” session delivered today at the American Academy of Neurology (AAN) Annual Meeting, Jessica Fesler,
Praxis Precision Medicines has reported encouraging results from its first-in-human clinical trial of vormatrigine (PRAX-628), a novel drug being developed
A groundbreaking clinical trial has been launched to evaluate BHV-7000, a novel treatment for idiopathic generalized epilepsy (IGE) with generalized
A groundbreaking long-term clinical trial has demonstrated that brivaracetam, when used as an add-on therapy, shows sustained effectiveness and safety
A major clinical trial has begun testing a promising new treatment for one of the most challenging forms of epilepsy.
A recent meta-analysis published in the journal Neurology has uncovered significant connections between common anti-seizure medications (ASMs) and potentially dangerous
A groundbreaking study presented at the 2025 American Academy of Neurology annual meeting has revealed that an extended-release oral formulation